Clinical Trials Update: June 26, 2007
Contraception Ulcerative Colitis Insomnia
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Women of childbearing capacity are invited to participate in this research study of an oral contraceptive. Women 18-45 may qualify who are willing to use the study drug as the only method of contraceptive, are not taking the herbal supplement St. John's Wort, and who do not have an abnormal Pap test, HPV, or untreated chlamydia.
The research site is in New York City.
Volunteers 18 or older with moderate-to-severe ulcerative colitis are welcome to participate in a research study of an approved drug. You may be eligible if you are not responding adequately to your current medication for ulcerative colitis.
The research site is in Cedar Knolls, NJ.
This study will evaluate an investigational medication for insomnia. Volunteers 18 or older whose lives are impacted by sleep problems may be eligible.
The research site is in Vero Beach, Fla.
Copyright 2007 Thomson CenterWatch. All rights reserved.